Identification of lung transplant candidates, stratification of risk, lung allocation and quality control in Europe using real-time decision-making and big data: lessons learned and future perspectives Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century Year: 2021
The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012
Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration Source: Eur Respir J 2009; 34: 1477-1486 Year: 2009
Drug development: news from “hot” early stage clinical trials: personalised immunotherapy for lung cancer Source: International Congress 2017 – Scientific year in review Year: 2017
Understanding the analysis of the Canadian lung volume reduction surgery (CLVR) trial: future applications Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008
Preliminary results of the impact of a French randomized feasibility trial of lung cancer screening on the quality of life, risk perception and smoking status: étude Dépiscan Source: Eur Respir J 2005; 26: Suppl. 49, 486s Year: 2005
Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020
Novel survey tool used to assess priorities of lung cancer patients and carers Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Implementation of lung cancer screening in Europe: the way forward Source: Virtual Congress 2020 – Thoracic oncology Year: 2020
A new WHO classification for lung cancer after 11 years: clinical implications Source: International Congress 2015 – Lung cancer pathology Year: 2015
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014
Asthma program characteristics associated with clinical health outcomes: examining practice in the field to increase chances for success Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007
Predicting future development of COPD (MARKO study) Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
Early detection of lung cancer – the NELSON trial results into real-life practice Source: ERS webinars 2019 - Early detection of lung cancer – the NELSON trial results into real-life practice Year: 2019
Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010